PL4308929T3 - Sposób diagnozy in vitro infekcji - Google Patents
Sposób diagnozy in vitro infekcjiInfo
- Publication number
- PL4308929T3 PL4308929T3 PL22717454.7T PL22717454T PL4308929T3 PL 4308929 T3 PL4308929 T3 PL 4308929T3 PL 22717454 T PL22717454 T PL 22717454T PL 4308929 T3 PL4308929 T3 PL 4308929T3
- Authority
- PL
- Poland
- Prior art keywords
- infection
- vitro diagnosis
- vitro
- diagnosis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/952—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2027785A NL2027785B1 (en) | 2021-03-19 | 2021-03-19 | Method for the in vitro diagnosis of infection |
| PCT/NL2022/050149 WO2022197186A1 (en) | 2021-03-19 | 2022-03-21 | Method for the in vitro diagnosis of infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4308929T3 true PL4308929T3 (pl) | 2026-03-09 |
Family
ID=81328265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL22717454.7T PL4308929T3 (pl) | 2021-03-19 | 2022-03-21 | Sposób diagnozy in vitro infekcji |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240168014A1 (pl) |
| EP (1) | EP4308929B1 (pl) |
| JP (1) | JP7621689B2 (pl) |
| KR (1) | KR102725628B1 (pl) |
| CN (1) | CN116940841A (pl) |
| AU (1) | AU2022238677B2 (pl) |
| CA (1) | CA3212118C (pl) |
| NL (1) | NL2027785B1 (pl) |
| PL (1) | PL4308929T3 (pl) |
| WO (1) | WO2022197186A1 (pl) |
| ZA (1) | ZA202308087B (pl) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0752097A4 (en) * | 1994-03-07 | 1997-12-10 | Coulter Corp | COVALENTLY IMMOBILIZED ANTIBODIES ON POLYMER PEARLS |
| US20050069898A1 (en) * | 2003-09-25 | 2005-03-31 | Cepheid | Lyophilized beads containing mannitol |
| US8609358B2 (en) | 2003-11-03 | 2013-12-17 | Systagenix Wound Management (Us), Inc. | Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria |
| WO2010002976A2 (en) * | 2008-07-03 | 2010-01-07 | Bracco Imaging S.P.A. | Enzyme-cleavable dye-containing fluor-quencher constructs |
| KR101103548B1 (ko) * | 2008-08-29 | 2012-01-09 | 한국과학기술연구원 | 단백질분해효소 활성 측정용 나노입자 센서 및 그 제조방법 |
| AU2009295623A1 (en) * | 2008-09-24 | 2010-04-01 | Stabilitech Ltd | Method for preserving polypeptides using a sugar and polyethyleneimine |
| GB0823315D0 (en) * | 2008-12-22 | 2009-01-28 | Ge Healthcare As | Fluorescent Probes |
| EP2578695A1 (en) * | 2011-10-05 | 2013-04-10 | Albert-Ludwigs-Universität Freiburg | Assay for Clostridium botulinum Neurotoxin |
| JP6107129B2 (ja) * | 2012-12-27 | 2017-04-05 | 東ソー株式会社 | 生体物質固定化微粒子の製造方法 |
| NL2013786B1 (en) * | 2014-11-13 | 2016-10-07 | Original G B V | Quenched coating. |
| JP7032081B2 (ja) * | 2016-09-05 | 2022-03-08 | 株式会社ファンケル | フェリチン検出用の検査キット及びフェリチンの検出方法 |
| PL3538665T3 (pl) | 2016-11-14 | 2024-05-06 | PPB Technology Pty Ltd | Cząsteczki czujnika proteazy |
| ES2886852T3 (es) | 2017-06-07 | 2021-12-21 | Original G B V | Método para detectar microbios que deterioran los alimentos |
-
2021
- 2021-03-19 NL NL2027785A patent/NL2027785B1/en active
-
2022
- 2022-03-21 CA CA3212118A patent/CA3212118C/en active Active
- 2022-03-21 JP JP2023557697A patent/JP7621689B2/ja active Active
- 2022-03-21 WO PCT/NL2022/050149 patent/WO2022197186A1/en not_active Ceased
- 2022-03-21 US US18/550,626 patent/US20240168014A1/en active Pending
- 2022-03-21 AU AU2022238677A patent/AU2022238677B2/en active Active
- 2022-03-21 KR KR1020237031491A patent/KR102725628B1/ko active Active
- 2022-03-21 CN CN202280020018.0A patent/CN116940841A/zh active Pending
- 2022-03-21 PL PL22717454.7T patent/PL4308929T3/pl unknown
- 2022-03-21 EP EP22717454.7A patent/EP4308929B1/en active Active
-
2023
- 2023-08-21 ZA ZA2023/08087A patent/ZA202308087B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3212118A1 (en) | 2022-09-22 |
| JP2024511762A (ja) | 2024-03-15 |
| EP4308929A1 (en) | 2024-01-24 |
| KR20230149829A (ko) | 2023-10-27 |
| AU2022238677B2 (en) | 2023-12-14 |
| EP4308929B1 (en) | 2025-11-12 |
| ZA202308087B (en) | 2024-03-27 |
| BR112023018203A2 (pt) | 2023-10-03 |
| WO2022197186A1 (en) | 2022-09-22 |
| JP7621689B2 (ja) | 2025-01-27 |
| KR102725628B1 (ko) | 2024-11-04 |
| CA3212118C (en) | 2024-03-19 |
| EP4308929C0 (en) | 2025-11-12 |
| NL2027785B1 (en) | 2022-09-29 |
| US20240168014A1 (en) | 2024-05-23 |
| CN116940841A (zh) | 2023-10-24 |
| AU2022238677A1 (en) | 2023-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2627644B (en) | Method for the preparation of GalNAc-lipid nanoparticle | |
| EP3323392A4 (en) | Smart menstrual cup and method for measuring menstrual blood using smart menstrual cup | |
| SMT202200435T1 (it) | Composti di c-mannoside utili per il trattamento di infezioni del tratto urinario | |
| HUE054864T2 (hu) | In vitro módszer tüdõrák diagnosztizálására | |
| GB202000926D0 (en) | Method of diagnosis | |
| SG11202101297UA (en) | Method for culturing cancer tissue or tissue analogous to cancer tissue | |
| EP3988072A4 (en) | MEDICAL VEST AND METHOD OF USE | |
| ZA202211512B (en) | An in vitro method for inducing the differentiation of hscs into tregs | |
| GB202000634D0 (en) | Diagnostic method | |
| GB202005231D0 (en) | Method of mimimising patient risk | |
| EP4308929C0 (en) | IN VITRO DIAGNOSTIC METHOD FOR AN INFECTION | |
| GB202102823D0 (en) | Diagnostic method | |
| CA203396S (en) | Medical probe | |
| GB202019317D0 (en) | Composition for the treatment of urinary tract infections | |
| GB202316905D0 (en) | Novel diagnostic method | |
| GB2609987B (en) | Diagnostic method | |
| GB2587656B (en) | Non-Invasive system for testing blood glucose and method of the same | |
| ZA202104921B (en) | Method for the manufacturing of chitin derivatives through treatment with ultrasounds | |
| HUP1800440A2 (hu) | In vitro eljárás rosszindulatú állapotok diagnosztizálására | |
| CA229196S (en) | Medical probe | |
| GB202316758D0 (en) | Diagnostic methods | |
| GB202312206D0 (en) | Methods and systems for the diagnosis of diseases | |
| HK40074613A (en) | Method and composition for the treatment of disease | |
| HK40089056A (en) | Methods for the diagnosis and treatment of biofilm-related infections | |
| AU2019904028A0 (en) | Methods for diagnosis and treatment |